Yakira Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Sell |
12,622
-2,500
| -17% | -$27.6K | 0.05% | 117 |
|
|
2025
Q1 | $135K | Hold |
15,122
| – | – | 0.05% | 111 |
|
|
2024
Q4 | $142K | Hold |
15,122
| – | – | 0.05% | 112 |
|
|
2024
Q3 | $122K | Hold |
15,122
| – | – | 0.04% | 118 |
|
|
2024
Q2 | $128K | Hold |
15,122
| – | – | 0.05% | 113 |
|
|
2024
Q1 | $136K | Hold |
15,122
| – | – | 0.04% | 126 |
|
|
2023
Q4 | $170K | Sell |
15,122
-1,776
| -11% | -$20K | 0.06% | 134 |
|
|
2023
Q3 | $146K | Hold |
16,898
| – | – | 0.04% | 148 |
|
|
2023
Q2 | $175K | Sell |
16,898
-15,758
| -48% | -$163K | 0.05% | 146 |
|
|
2023
Q1 | $354K | Buy |
32,656
+1,128
| +4% | +$12.2K | 0.09% | 131 |
|
|
2022
Q4 | $354K | Sell |
31,528
-27,572
| -47% | -$309K | 0.07% | 156 |
|
|
2022
Q3 | $599K | Buy |
+59,100
| New | +$599K | 0.09% | 189 |
|